These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19620307)
1. Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity. Honda M; Wang R; Kong WP; Kanekiyo M; Akahata W; Xu L; Matsuo K; Natarajan K; Robinson H; Asher TE; Price DA; Douek DC; Margulies DH; Nabel GJ J Immunol; 2009 Aug; 183(4):2425-34. PubMed ID: 19620307 [TBL] [Abstract][Full Text] [Related]
2. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. Wang X; Uto T; Akagi T; Akashi M; Baba M J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261 [TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand. Sailaja G; Husain S; Nayak BP; Jabbar AM J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275 [TBL] [Abstract][Full Text] [Related]
4. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. Schirmbeck R; Fissolo N; Chaplin P; Reimann J J Immunol; 2003 Aug; 171(3):1240-6. PubMed ID: 12874211 [TBL] [Abstract][Full Text] [Related]
5. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. Singh RA; Barry MA J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568 [TBL] [Abstract][Full Text] [Related]
6. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024 [TBL] [Abstract][Full Text] [Related]
7. HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime. Duke CM; Maguire CA; Keefer MC; Federoff HJ; Bowers WJ; Dewhurst S Vaccine; 2007 Oct; 25(42):7410-21. PubMed ID: 17868958 [TBL] [Abstract][Full Text] [Related]
8. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE; Abaitua F; Rodríguez D; Esteban M Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant. Gómez CE; Perdiguero B; Falqui M; Marín MQ; Bécares M; Sorzano CÓS; García-Arriaza J; Esteban M; Guerra S J Virol; 2020 Dec; 95(2):. PubMed ID: 33115866 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity. Shata MT; Hone DM J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798 [TBL] [Abstract][Full Text] [Related]
11. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector. Gómez CE; Rodríguez D; Rodríguez JR; Abaitua F; Duarte C; Esteban M Vaccine; 2001 Dec; 20(5-6):961-71. PubMed ID: 11738764 [TBL] [Abstract][Full Text] [Related]
12. Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations. Hill BJ; Darrah PA; Ende Z; Ambrozak DR; Quinn KM; Darko S; Gostick E; Wooldridge L; van den Berg HA; Venturi V; Larsen M; Davenport MP; Seder RA; Price DA; Douek DC J Immunol; 2014 Dec; 193(11):5626-36. PubMed ID: 25348625 [TBL] [Abstract][Full Text] [Related]
13. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882 [TBL] [Abstract][Full Text] [Related]
14. Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. Vázquez Blomquist D; Green P; Laidlaw SM; Skinner MA; Borrow P; Duarte CA Viral Immunol; 2002; 15(2):337-56. PubMed ID: 12081016 [TBL] [Abstract][Full Text] [Related]
15. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604 [TBL] [Abstract][Full Text] [Related]
16. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448 [TBL] [Abstract][Full Text] [Related]
17. Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens. Perdiguero B; Gómez CE; Nájera JL; Sorzano CO; Delaloye J; González-Sanz R; Jiménez V; Roger T; Calandra T; Pantaleo G; Esteban M PLoS One; 2012; 7(10):e48524. PubMed ID: 23119046 [TBL] [Abstract][Full Text] [Related]
18. A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice. Buffa V; Negri DRM; Leone P; Bona R; Borghi M; Bacigalupo I; Carlei D; Sgadari C; Ensoli B; Cara A J Gen Virol; 2006 Jun; 87(Pt 6):1625-1634. PubMed ID: 16690927 [TBL] [Abstract][Full Text] [Related]